A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

Clinical trial NCT00191750 · COMPLETED

Trial details

NCT number: NCT00191750
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Small Cell

Start date: 2004-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.